3BNC117-LS-J
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 3BNC117-LS-J, covering 2025-05-06 to 2025-05-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults [Phase 1, Phase 2]